Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000056739) titled 'Introduction of Novel Liquid Biopsy in Genomic Medicine' on Jan. 20.
Study Type:
Observational
Primary Sponsor:
Institute - Seta Clinic Tokyo
Condition:
Condition - Malignant tumor
Healthy person
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - Operational evaluation of two types of liquid biopsy offered by GC genome
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - ･Patients or healthy persons visiting Seta Clinic Tokyo who wish to undergo "DNA CT...